Corentec Co., Ltd.

KOSDAQ:A104540 Stock Report

Market Cap: ₩81.1b

Corentec Past Earnings Performance

Past criteria checks 1/6

Corentec's earnings have been declining at an average annual rate of -27.1%, while the Medical Equipment industry saw earnings growing at 19.9% annually. Revenues have been growing at an average rate of 22.3% per year. Corentec's return on equity is 1.8%, and it has net margins of 0.4%.

Key information

-27.13%

Earnings growth rate

-30.24%

EPS growth rate

Medical Equipment Industry Growth22.66%
Revenue growth rate22.27%
Return on equity1.75%
Net Margin0.43%
Last Earnings Update31 Mar 2025

Recent past performance updates

Should You Use Corentec's (KOSDAQ:104540) Statutory Earnings To Analyse It?

Dec 24
Should You Use Corentec's (KOSDAQ:104540) Statutory Earnings To Analyse It?

Recent updates

Does Corentec (KOSDAQ:104540) Have A Healthy Balance Sheet?

Apr 10
Does Corentec (KOSDAQ:104540) Have A Healthy Balance Sheet?

Lacklustre Performance Is Driving Corentec Co., Ltd.'s (KOSDAQ:104540) Low P/S

Jan 06
Lacklustre Performance Is Driving Corentec Co., Ltd.'s (KOSDAQ:104540) Low P/S

Corentec's (KOSDAQ:104540) Returns On Capital Are Heading Higher

Nov 14
Corentec's (KOSDAQ:104540) Returns On Capital Are Heading Higher

Does Corentec (KOSDAQ:104540) Have A Healthy Balance Sheet?

Sep 10
Does Corentec (KOSDAQ:104540) Have A Healthy Balance Sheet?

Corentec Co., Ltd.'s (KOSDAQ:104540) Shares May Have Run Too Fast Too Soon

May 28
Corentec Co., Ltd.'s (KOSDAQ:104540) Shares May Have Run Too Fast Too Soon

These 4 Measures Indicate That Corentec (KOSDAQ:104540) Is Using Debt Reasonably Well

May 09
These 4 Measures Indicate That Corentec (KOSDAQ:104540) Is Using Debt Reasonably Well

Returns On Capital Are Showing Encouraging Signs At Corentec (KOSDAQ:104540)

Mar 31
Returns On Capital Are Showing Encouraging Signs At Corentec (KOSDAQ:104540)

Corentec Co., Ltd.'s (KOSDAQ:104540) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Feb 15
Corentec Co., Ltd.'s (KOSDAQ:104540) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Should You Use Corentec's (KOSDAQ:104540) Statutory Earnings To Analyse It?

Dec 24
Should You Use Corentec's (KOSDAQ:104540) Statutory Earnings To Analyse It?

Revenue & Expenses Breakdown

How Corentec makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A104540 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2597,25242039,2651,872
31 Dec 2493,667-2,58540,0571,528
30 Sep 2493,258-3,92439,3201,509
30 Jun 2494,903-1,57940,3681,758
31 Mar 2491,9272,85838,7231,528
31 Dec 2392,0464,05538,8811,487
30 Sep 2382,7792,78638,5471,077
30 Jun 2376,0044,36636,706761
31 Mar 2371,1532,12534,443791
31 Dec 2263,9091,78130,288734
30 Sep 2256,3492,64725,919760
30 Jun 2249,64627522,089899
31 Mar 2245,93733521,237-155
31 Dec 2144,63076421,061-196
30 Sep 2144,1591,86919,891-288
30 Jun 2142,8881,61119,406-257
31 Mar 2141,1661,58518,357432
31 Dec 2040,4961,57418,000503
30 Sep 2039,2372,84317,879767
30 Jun 2039,5642,88518,007662
31 Mar 2039,8393,28817,9841,098
31 Dec 1940,1892,50618,2501,152
30 Sep 1935,277-26,72218,044237
30 Jun 1934,180-26,70317,766389
31 Mar 1934,510-28,64719,064447
31 Dec 1833,406-29,76318,483554
30 Sep 1836,247-9,55219,2321,947
30 Jun 1836,589-10,07219,2322,213
31 Mar 1836,568-8,73418,2732,074
31 Dec 1737,634-7,86118,1741,896
30 Sep 1738,24333317,5031,041
30 Jun 1737,683-6617,131590
31 Mar 1737,1577917,088349
31 Dec 1635,97446616,665225
30 Sep 1634,87916915,734311
30 Jun 1634,15034915,548263
31 Mar 1632,017-58214,742173
31 Dec 1530,347-85914,260157
30 Sep 1529,454-92213,81794
30 Jun 1527,970-1,12613,074166
31 Mar 1526,922-1,64312,722185
31 Dec 1426,583-1,46612,360163
30 Sep 1425,59496312,061131
30 Jun 1426,1541,52811,96034

Quality Earnings: A104540 has a large one-off loss of ₩625.6M impacting its last 12 months of financial results to 31st March, 2025.

Growing Profit Margin: A104540's current net profit margins (0.4%) are lower than last year (3.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A104540 has become profitable over the past 5 years, growing earnings by -27.1% per year.

Accelerating Growth: A104540's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A104540 had negative earnings growth (-85.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (-10.6%).

Return on Equity

High ROE: A104540's Return on Equity (1.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/29 02:15
End of Day Share Price 2025/05/29 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Corentec Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Byung Hwa LeeShinhan Investment Corp.